Literature DB >> 15150090

Dependence of the cytotoxicity of DNA-damaging agents on the mismatch repair status of human cells.

Efterpi Papouli1, Petr Cejka, Josef Jiricny.   

Abstract

Mismatch repair (MMR) deficiency was reported to increase resistance of mammalian cells to killing by several genotoxic substances. However, although MMR-deficient cells are approximately 100-fold more resistant to killing by S(N)1 type methylating agents than MMR-proficient controls, the sensitivity differences reported for the other agents were typically <2-fold. To test whether these differences were linked to factors other than MMR status, we studied the cytotoxicities of mitomycin C, chloroethylcyclohexyl nitrosourea, melphalan, psoralen-UVA, etoposide, camptothecin, ionizing radiation, and cis-dichlorodiaminoplatinum (cisplatin) in a strictly isogenic system. We now report that MMR deficiency reproducibly desensitized cells solely to cisplatin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150090     DOI: 10.1158/0008-5472.CAN-04-0513

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.

Authors:  John M Carethers
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

2.  Mismatch repair proteins are activators of toxic responses to chromium-DNA damage.

Authors:  Elizabeth Peterson-Roth; Mindy Reynolds; George Quievryn; Anatoly Zhitkovich
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

3.  Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer.

Authors:  J M Carethers
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

4.  Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.

Authors:  Daniel P Cahill; Kymberly K Levine; Rebecca A Betensky; Patrick J Codd; Candice A Romany; Linsey B Reavie; Tracy T Batchelor; P Andrew Futreal; Michael R Stratton; William T Curry; A John Iafrate; David N Louis
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

5.  Molecular signaling mechanisms of apoptosis in hereditary non-polyposis colorectal cancer.

Authors:  Samar Hassen; Nawab Ali; Parimal Chowdhury
Journal:  World J Gastrointest Pathophysiol       Date:  2012-06-15

Review 6.  Chemotherapeutic implications in microsatellite unstable colorectal cancer.

Authors:  Won-Seok Jo; John M Carethers
Journal:  Cancer Biomark       Date:  2006       Impact factor: 4.388

7.  Evidence for a direct involvement of hMSH5 in promoting ionizing radiation induced apoptosis.

Authors:  Joshua D Tompkins; Xiling Wu; Yen-Lin Chu; Chengtao Her
Journal:  Exp Cell Res       Date:  2009-05-12       Impact factor: 3.905

8.  Cellular responses to Cisplatin-induced DNA damage.

Authors:  Alakananda Basu; Soumya Krishnamurthy
Journal:  J Nucleic Acids       Date:  2010-08-08

9.  Mismatch repair protein deficiency compromises cisplatin-induced apoptotic signaling.

Authors:  Ryan P Topping; John C Wilkinson; Karin Drotschmann Scarpinato
Journal:  J Biol Chem       Date:  2009-03-13       Impact factor: 5.157

10.  Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity.

Authors:  Brendon Ladd; Jeffrey J Ackroyd; J Kevin Hicks; Christine E Canman; Sheryl A Flanagan; Donna S Shewach
Journal:  DNA Repair (Amst)       Date:  2013-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.